is glipizide a glp-1 New Guidelines for Type 2 Diabetes in 2025 Glipizide - an overview |

The majority of the reported events occurred in patients who experienced gastrointestinal reactions leading to dehydration such as nausea, vomiting, or diarrhea [see Adverse Reactions (6.1)]

Its difficult to distinguish direct anti-inflammatory effects from the benefits of weight loss and improved metabolic health, but the pattern is consistent enough to warrant further study. A 2025 study found that RA patients with a BMI over 27 taking GLP-1 medications showed improvements in symptoms and disease activity

Biochimie , 165 , 250-257

Acknowledgments We would like to thank Editage (www.editage.cn) for English language editing

The effect of glucagon-like peptide-1 (GLP-1) receptor agonists on substance use disorder (SUD)-related behavioural effects of drugs and alcohol: A systematic review

Gastric emptying is a key mechanism in dumping syndrome